Dr. Emily Chen specializes in the molecular mechanisms of cancer and the development of targeted therapies. As the Lead Research Scientist at OncoVanta Therapeutics, she drives the scientific exploration of mutant TP53 pathways to develop effective immunotherapies. With a PhD in Molecular Biology, Dr. Chen employs her extensive knowledge to design experiments that yield impactful results. Her innovative mindset and collaborative spirit contribute to the continuous improvement of therapeutic strategies. Dr. Chen is passionate about mentoring young scientists, fostering a future generation dedicated to advancing cancer research and treatment.